Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

by

CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even for patients regarded as high risk due to comorbidities.

Leave A Comment

Your email address will not be published. Required fields are marked *